000
| 01189cas 2200265za 4500 |
---|
001 | 9.507530 |
---|
003 | CaOODSP |
---|
005 | 20221107133807 |
---|
007 | cr ||||||||||| |
---|
008 | 150406d20122019oncqr p o||||f0 a0eng|d |
---|
022 | |a2561-5572 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH2-2E-PDF |
---|
222 | 0|aDrug submission performance quarterly report ... |b(Canada. Biologics and Genetic Therapies Directorate) |
---|
245 | 00|aDrug submission performance quarterly report ... |h[electronic resource] / |cBiologics and Genetic Therapies Directorate. |
---|
246 | 37|aBGTD quarterly drug submission performance report |
---|
260 | |aOttawa : |bHealth Canada, |c2012-2019. |
---|
310 | |aQuarterly |
---|
362 | 1 |aBegan with: Jan.-Mar. 2012; suspended with July-Sept. 2012; resumed with Oct.-Dec. 2017; ceased with Oct.-Dec. 2019. |
---|
500 | |aIssued also in French under title: Rapport trimestriel du rendement des présentations de drogue... |
---|
692 | 07|2gccst|aDrugs |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
775 | 08|tRapport trimestriel du rendement des présentations de drogue ... |w(CaOODSP)9.503920 |
---|
785 | 00|tDrug submission performance quarterly report / |w(CaOODSP)9.893870 |
---|